Pregled bibliografske jedinice broj: 1165991
The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia
The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia // Blood Transfusion, 20 (2021), 4; 319-328 doi:10.2450/2021.0235-21 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1165991 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune
haemolytic anaemia
(The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia)
Autori
Raos, Mirela ; Lukić, Marija ; Pulanić, Dražen ; Vodanović, Marijo ; Golubić Ćepulić, Branka
Izvornik
Blood Transfusion (1723-2007) 20
(2021), 4;
319-328
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
autoimmune haemolytic anaemia ; genotyping ; molecular testing ; serological testing ; transfusion
Sažetak
Autoimmune haemolytic anaemia (AIHA) is a rare autoimmune disease characterised by haemolysis associated with the presence of immunoglobulins and/or components of the complement system on red blood cells (RBCs). It is classified into warm or cold antibody-mediated AIHA according to the temperature at which autoantibodies bind optimally to RBCs. Clinicians should be familiar with the procedural tests used for a complete laboratory investigation of AIHA. Good collaboration between clinicians and laboratory specialists with correct sample handling and an exact diagnostic work-up is extremely important for the correct classification and proper therapeutic management of AIHA. Specialised serological test procedures are very complex. Problems with serological testing may be excluded with the molecular testing, which has now become a gold standard to predict a patient’s phenotype in order to secure the right antigen- matched blood for AIHA patients. More recently, genotyping has been used instead of serological typing and complex adsorption tests. This paper offers a description of various tests for differentiating between types of AIHA. A diagnostic algorithm and the problems of laboratory investigation are also presented, and an application of molecular methods for the blood group typing in AIHA is elaborated.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Zdravstveno veleučilište, Zagreb,
Medicinski fakultet, Osijek,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija
Profili:
Marija Lukić
(autor)
Branka Golubić Ćepulić
(autor)
Dražen Pulanić
(autor)
MARIJO VODANOVIĆ
(autor)
Mirela Raos
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE